The Society for Immunotherapy of Cancer (SITC) is pleased to offer a highly anticipated series of eight, online seminars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format.
Register Now for Targets for Cancer Immunotherapy: A Deep Dive Seminar Series
Basic, clinical and translational researchers in academia and industry and members of the investment community.
View Registration Rates
If you have questions about this webinar series, please contact the SITC Education team.
Targets for Cancer Immunotherapy: A Deep Dive Seminar Series is supported, in part, by grants from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, and Merck & Co., Inc. (as of 5/18/2021).Interested in supporting this program? The SITC Development team would love to work with you. Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org